← ANALYSTS · TIPRANKS
Joseph Schwartz · Leerink Partners
Hits
54%
272 of 505 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+31.9%
Over a year after the rating, TipRanks’ measure
Our companies rated now
18
Buy / hold / sell: 14 / 4 / 0
Upside of the analyst’s targets
+143.2%
Average over 16 current targets, to the last price
The market’s answer to the ratings
+11.8%
Day-0 move against SPY in the rating’s direction, average over 9 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Sep 28on TipRanks Sep 29 00:55 | MIRMIWMMirum Pharmaceuticals · $5.3B | Reiterated | Buy | $154 | +92.2% | −1.2%next day −0.3% · 5 days −8.6% | ↗ |
| Sep 23on TipRanks Sep 25 04:35 | EWTXIWMEdgewise Therapeutics · $4.1B | Reiterated | Buy | — | — | −7.1%next day +0.4% · 5 days −0.4% | ↗ |
| Sep 18on TipRanks 08:30 | RAREIWMUltragenyx Pharmaceutical · $1.5B | Reiterated | Buy | $33.00 | +127.0% | −0.1%next day −0.6% · 5 days −1.3% | ↗ |
| Sep 16on TipRanks 08:55 | SLDBIWMSolid Biosciences · $615M | Reiterated | Buy | $20.00 | +261.7% | +4.6%next day +0.6% · 5 days −10.1% | ↗ |
| Sep 10on TipRanks Sep 9 08:50 | PHVSPharvaris · $2.1B | Assigned | Buy | $50.00 → $65.00+30.0% | +134.3% | +0.2%next day 0.0% · 5 days +0.6% | ↗ |
| Jun 17on TipRanks Jun 18 07:31 | QUREuniQure · $1.5B | Reiterated | Buy | $36.00 → $70.00+94.4% | +221.4% | +79.7%next day −4.9% · 5 days +2.6% | ↗ |
| Jun 2on TipRanks Jun 4 22:00 | ASNDAscendis Pharma · $13.9B | Reiterated | Buy | $305 | +35.4% | −1.1%next day +0.8% · 5 days +1.4% | ↗ |
| Jun 2on TipRanks 06:13 | FULCIWMFulcrum Therapeutics · $280M | Downgrade | Hold | $24.00 → $4.00−83.3% | +9.6% | −51.2%next day +3.2% · 5 days +15.1% | ↗ |
| May 18on TipRanks 14:55 | BMRNBioMarin Pharmaceutical · $10.8B | Reiterated | Hold | $62.00 | +13.4% | −4.1%next day +0.9% · 5 days +4.8% | ↗ |
| May 15on TipRanks 11:20 | SPRBIWMSpruce Biosciences · $119M | Reiterated | Buy | $140 → $120−14.3% | +202.6% | −7.6%next day −4.3% · 5 days −5.9% | ↗ |
| May 15on TipRanks 10:45 | RNAIWMAtrium Therapeutics, Inc. · $171M | Initiated | Buy | $25.00 | +225.9% | +0.9%next day −2.0% · 5 days −1.9% | ↗ |
| May 15on TipRanks May 14 06:15 | ANTXIWMAN2 Therapeutics, Inc. · $136M | Upgrade | Buy | $9.00 | +166.3% | +6.9%next day +3.6% · 5 days +6.1% | ↗ |
| Mar 26on TipRanks 09:10 | WVEIWMWave Life Sciences · $629M | Reiterated | Buy | $35.00 → $25.00−28.6% | +698.7% | −47.8%next day +4.4% · 5 days +15.8% | ↗ |
| Mar 25on TipRanks 10:15 | SRPTIWMSarepta Therapeutics · $1.9B | Reiterated | Hold | $15.00 | −12.3% | +34.4%next day −7.0% · 5 days −6.7% | ↗ |
| Mar 25on TipRanks 09:50 | MAZEIWMMaze Therapeutics, Inc. · $1.5B | Reiterated | Buy | $50.00 | +81.6% | −35.8%next day +1.7% · 5 days −8.2% | ↗ |
| Jan 13on TipRanks 14:59 | TVTXIWMTravere Therapeutics · $5.0B | Reiterated | Buy | — | — | −14.4%next day −0.1% · 5 days −1.7% | ↗ |
| Dec 3on TipRanks 07:55 | DSGNIWMDesign Therapeutics · $656M | Upgrade | Buy | $14.00 | +35.8% | +8.9%next day +0.4% · 5 days −4.1% | ↗ |
| Dec 3on TipRanks 07:55 | AUPHIWMAurinia Pharmaceuticals · $2.2B | Downgrade | Hold | $16.00 | −3.1% | −6.6%next day +2.6% · 5 days +3.2% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗